CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Caplin Point jumps on USFDA approval for tranexamic acid inj
Nidhi Jani
/ Categories: Trending

Caplin Point jumps on USFDA approval for tranexamic acid inj

Caplin Point informed the bourses that its arm, Caplin Steriles Limited has received final approval from USFDA for its Abbreviated New Drug Application (ANDA) tranexamic acid injection USP, 1000mg/10ml.

Tranexamic acid injection is used to reduce bleeding in the surgeries like dental surgery and cervical surgery, heavy menstrual bleeding, nose bleeds and bleeding inside the eye.

As per IQVIA data, tranexamic acid had sales of around US$ 30 million for 12 months period ending March 2019 in US.

Caplin Steriles, has developed and filed 11 ANDAs out of which 5 are approved. The company is also working on a portfolio of 35 simple and complex injectable and ophthalmic products which would be filed in the next 4 years.

Caplin Point Laboratories is engaged in the manufacturing of a wide range of ointments, creams and other external application preparations in addition to the regular segments of pharmaceutical formulations.

Cheering this development, the stock of Caplin Point Laboratories jumped by nearly 4 per cent and made an intraday high of Rs. 429.80 per share on BSE. At 12:00 hours, the stock was trading at Rs. 426.15. The stock had hit its 52-week high of Rs. 535 on September 10, 2018 and its 52-week low of Rs. 304.75 on January 29, 2019 on BSE.

Previous Article Budget 2019 Highlights Pertaining To Direct Taxes
Next Article NMDC reports 28 per cent rise in sales volumes for H1CY19
Print
1682 Rate this article:
4.0
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR